DCM, dilated cardiomyopathy

Brain natriuretic peptide predicts survival in Chagas’ disease more effectively than atrial natriuretic peptide
S Heringer-Walther, M C V Moreira, N Wessel, J L Saliba, J Silvia-Barra, J L B Pena, S Becker, W E Siems, H P Schultheiss, T Walther

Heart Mar 2005, 91 (3) 385-387; DOI: 10.1136/hrt.2003.026856
Heart failure: aetiology, diagnosis, and treatment
C George

Heart Dec 2002, 88 (6) 567-569; DOI: 10.1136/heart.88.6.567
Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure
E Bollano, M Scharin Täng, Å Hjalmarson, F Waagstein, B Andersson

Heart Jun 2003, 89 (6) 621-624; DOI: 10.1136/heart.89.6.621
Nitric oxide and myocardial function in heart failure: friend or foe?
J M Cotton, M T Kearney, A M Shah

Heart Dec 2002, 88 (6) 564-566; DOI: 10.1136/heart.88.6.564
Association between aldosterone synthase (CYP11B2) gene polymorphism and left ventricular volume in patients with dilated cardiomyopathy
E Takai, H Akita, K Kanazawa, N Shiga, M Terashima, Y Matsuda, C Iwai, Y Miyamoto, H Kawai, A Takarada, M Yokoyama

Heart Dec 2002, 88 (6) 649-650; DOI: 10.1136/heart.88.6.649
A 17 year experience of inappropriate shock therapy in patients with implantable cardioverter-defibrillators: are we getting any better?
C A Rinaldi, R D Simon, A Baszko, J Bostock, D Elliot, C A Bucknall, J S S Gill

Heart Mar 2004, 90 (3) 330-331; DOI: 10.1136/hrt.2003.026195

Main menu